Skip to content
Research/Exosome Therapy/USC-Exos

USC-Exos

USC-Exos are exosomes derived from urine-derived stem cells (USCs). They are being explored for their potential in regenerative medicine due to their ability to facilitate cell communication and promote tissue repair. This could be significant for longevity and health optimization by enhancing the body's natural repair mechanisms.

Intelligence Profile

Clinical Applications

USC-Exos Clinical Applications

USC-Exos, exosomes derived from urine-derived stem cells, hold potential for various therapeutic applications based on emerging clinical and preclinical research.

  1. Renal Fibrosis: USC-Exos have shown promise in mitigating renal fibrosis. Studies highlight miR-26a-5p in these exosomes targeting and downregulating NRAS, reducing fibrosis in kidney tissues (FASEB J, 2026).

  2. Ischemic Stroke: Animal model meta-analyses suggest USC-Exos play a role in recovering from ischemic stroke by minimizing damage and supporting neuronal recovery through various mechanisms (Front Pharmacol, 2024).

  3. Bone Regeneration: These exosomes are involved in enhancing bone regeneration, especially in alveolar bone and critical-sized defects when used with biomimetic scaffolds or injectable hydrogels. They regulate energy metabolism essential for bone healing (Theranostics, 2026; Materials Today Bio, 2023).

  4. Osteoarthritis: For temporomandibular joint osteoarthritis, USC-Exos demonstrate therapeutic effects by potentially reducing inflammation and promoting joint health (FASEB J, 2024).

  5. Fibrosis and Inflammation in Kidney Injury: USC-Exos may inhibit kidney fibrosis and inflammation, targeting pathways like miR-122-5p/SOX2, offering a novel approach for obstructive kidney injury management (Biomaterials Res, 2024).

  6. Acute Kidney Injury (AKI): Exosomes from urine-derived stem cells show potential in mitigating ischemia-reperfusion-induced AKI through inhibition of cell death pathways (Chem Biol Interact, 2024).

  7. Musculoskeletal Repair: Exosomes have been found to aid rotator cuff healing by mediating interactions with bone marrow mesenchymal stem cells, enhancing repair outcomes (J Orthop Translat, 2023).

  8. Reproductive and Urological Health: Clinical trials are investigating USC-Exos for urogenital applications, including corpus spongiosum reconstruction in hypospadias and treatment for post-prostatectomy erectile dysfunction (NCT07495176; NCT07707505).

Overall, USC-Exos demonstrate multifaceted potential in treating diverse conditions, from renal and joint health to neurological recovery and tissue regeneration. Further research will elucidate their full therapeutic potential and clinical applications.

Disclaimer: This summary provides general information and is not a substitute for professional medical advice. Consult a healthcare provider for personalized medical guidance.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.